Tag: RELAZA2

Can MRD-guided azacitidine treatment improve outcomes in AML and MDS?

Presented By
Dr Anne Sophie Kubasch, University of Leipzig, Germany
Trial
Phase 2, RELAZA2
Conference
EHA 2024
Type
Peer-reviewed article

12 August 2024 14:19

MRD assessment to guide pre-emptive treatment decisions

Presented By
Prof. Uwe Platzbecker, University Hospital Carl Gustav Carus, Germany
Trial
Phase 2, RELAZA2
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 16:04
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com